CPRX FY 2020 Earnings — Catalyst Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

CPRXCatalyst Pharmaceuticals, Inc.

$3B

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$119M+16.4% YoY

Gross Profit

$102M85.7% margin

Operating Income

$41M34.7% margin

Net Income

$75M63.0% margin

EPS (Diluted)

$0.71

Cash Flow

Operating Cash Flow

$45M

Free Cash Flow

$45M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$192M

Total Liabilities

$23M

Stockholders' Equity

$170M

Cash & Equivalents

$130M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$119M	$102M	+16.4%
Gross Profit	$102M	$88M	+16.5%
Operating Income	$41M	$32M	+29.8%
Net Income	$75M	$32M	+135.2%